Brief: Diagnos announces restatement of March 31, 2017 financial statements which resulted in a decrease in expenses of $2,491,096

Diagnos

28/08/2017 20:34

Aug 28 (Reuters) - Diagnos Inc  ADK.V  
    * Diagnos announces restatement of March 31, 2017 financial 
statements which resulted in a decrease in expenses of 
$2,491,096 
    * Diagnos - restatement resulted in a comprehensive loss of 
$2.8 million, basic diluted comprehensive loss per share of 
$0.02 for year ended March 31, 2017 
 
Source text for Eikon:  ID:nCCN58wHVa  
Further company coverage:  ADK.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))